Le Lézard
Classified in: Health
Subjects: NPT, VET, FVT

TRR Comedy Night Hosted By Stand Up NY


NEW YORK, June 26, 2019 /PRNewswire/ -- Trauma and Resiliency Resources is pleased to announce that Stand Up NY will be donating 60% of the proceeds of Pete Stegemeyer's July 8th Mandatory Fun show to TRR and it's Warrior Camp® program. The July 8th show will feature military veteran comics Pete Stegemeyer, Jess Miller, Linette Palladino and Patrick James Loller and a big name comedian who will be announced soon. Please join us for a night of humor and entertainment that will support our mission to end military veteran suicide.

(PRNewsfoto/Trauma and Resiliency Resources)

To purchase tickets to the show: https://standupny.laughstub.com/event.cfm?id=529917

Military Veterans receive a discount: enter VETSRULE.

TRR's Warrior Camp® is an award-winning program, designed to prevent suicide, resolve trauma, enhance resilience and support force preservation. TRR's approach is unique in that we focus on Moral Injury as a core component of combat trauma. Moral Injury is not PTSD. Moral Injury is not a disorder. Moral Injury results from having been trained to override the intrinsic aversion to the taking of human life. It can occur during combat operations, when one's actions and moral compass don't align. It is a very human response. Healing Moral Injury in our Nation's warfighters is key to their survival.

Trauma and Resiliency Resources is a 501(c)3 public charity based in New York. So far TRR has conducted 12 7-day Warrior Camp® programs and has a 100% survival rate post program - we have lost no one to suicide. We will soon be expanding services to first responders and families.

For more information about TRR and how you can help please contact Erick Toribio at (855) 877-4968 or email [email protected]. Web address is www.trrhelp.org

Contact Eva Usadi
Phone: (917) 509-5804
Email: [email protected]

SOURCE Trauma and Resiliency Resources, Inc.


These press releases may also interest you

at 07:55
The "KEYTRUDA Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights about KEYTRUDA for ovarian cancer in the seven major markets. A detailed...

at 07:50
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...



News published on and distributed by: